• 1
    Gutman, A. B., and Yu, T. F.: Benemid as uricosuric agent in chronic gouty arthritis. Tr. Ass. Amer. Phys. 64: 279, 1951.
  • 2
    Sirota, J. H., Yu, T. F., and Gutman, A. B.: Effect of benemid on urate clearance and other discrete renal function tests in gouty subjects. J. Clin. Invest. 31: 692, 1952.
  • 3
    Bums, J. J., Yu, T. F., Ritterband, A., Perel, J. M., Gutman, A. B., and Brodie, B. B.: A potent new uricosuric agent., the sulfoxide metabolite of the phenylbutazone analogue G25671. J. Pharm. and Exp. Therapeutics 119: 418, 1957.
  • 4
    Brodie, B. B., Yu, T. F., Bums, J. J., Chenkin, T., Paton, B. C., Steele, J. M., and Gutman, A. B.: Observations on G25671, a phenylbutazone analogue. Proc. Soc. Exper. Biol. & Med. 86: 884, 1954.
  • 5
    Reed, E. G., Feichtmeir, T. V., and Willett, F. M.: Zoxazolamine, a potent uricosuric agent. New England J. Med. 258: 394, 1958.
  • 6
    Burns, J. J., Yu, T. F., Berger, L., and Gutman, A. B.: Zoxazolamine, physiological physiological disposition and uricosuric properties. Am. J. Med. 25: 401, 1958.
  • 7
    Marson, F. G. W.: Effect of ACTH and sodium salicylate on the urinary uric acid: creatinine ratio., and circulating eosinophils in man. Ann. Rheumat. Dis. 12: 296, 1953.
  • 8
    Marson, F. G. W.: Sodium salicylate and probenecid in the treatment of chronic gout. Ann. Rheumat. Dis. 13: 233, 1954.
  • 9
    Seegmiller, J. E.: Role of the newer uricosuric agents in management of gout. Bull. Rheumat. Dis. 11: 241, 1961.
  • 10
    Gutman, A. B., and Yu, T. F.: Protracted uricosuric therapy in tophaceous gout. Lancet 2: 1258, December 21, 1957.
  • 11
    Ogryzlo, M. A., and Harrison, J.: Evaluation of uricosuric agents in chronic gout. Ann. Rheumat. Dis. 16: 425, 1957.
  • 12
    Smyth, C. J., Frank, L. S., and Hoffman, E. R.: Urate diuretic therapy in chronic gout. Arch. Interamer. Rheumat. 3: 3, 1960.
  • 13
    Bartels, E. C., and Matossian, G. S.: Gout, six-year follow-up on pro benecid (benemid) therapy. Arth. and Rheumat. 2: 193, 1959.
  • 14
    Kersley, G. D., and Gibbs, A. R.: Uricosuric agents in the treatment of gout. Ann. Rheumat. Dis. 19: 351, 1960.
  • 15
    Talbott, J. H.: Current concepts of gout. Arch. Interamer. Rheumat. 1: 81, 1958.
  • 16
    Talbott, J. H.: Gout and Gouty Arthritis. Modem Medical Monographs; New York., Gruneand Stratton., 1953.
  • 17
    Gutman, A. B.: Some recent advances in the study of uric acid metabolism and gout. Bull. New York Acad. Med. 27: 144, 1951.
  • 18
    Smyth, C. J. et al: The uric acid problem- Thirteenth rheumatism review. Ann. Int. Med. 53: 144, 1960.
  • 19
    Seegmiller, J. E., Grazel, A. I., Laster, L., and Liddle, L.: Uric acid production in gout. J. Clin. Invest. 40: 1304, 1961.
  • 20
    Bonsnes, R. W., and Taussky, H. H.: On the colorimetric determination of creatinine by the Jaffe reaction. J. Biol. Chem. 158: 581, 1945.
  • 21
    Block, W. D., and Geib, N. C.: An enzymatic method for the determination of uric acid in whole blood. J. Biol. Chem. 168: 747, 1947.
  • 22
    Gutman, A. B., and Yu, T. F.: Renal regulation of uric acid excretion in normal and gouty man: modification by uricosuric agents. Bull. New York Acad. Med. 34: 287, 1958.
  • 23
    Gutman, A. B., and Yu, T. F., and Yu, T. F.: Renal function in gout. Am. J. Med. 23: 600, 1957.
  • 24
    Blatt, I. M., Mikkelsen, W. M., and Denning, R. M.: Studies in sialolithiasis II. Uric acid calculus of the parotid gland: Report of a case. Ann. Otol. Rhin. & Laryng. 67: 1022, 1958.
  • 25
    Phillips, R. W.: Reversal of renal insufficiency in gout. A. M. A. Arch. Int. Med. 96: 823, 1955.
  • 26
    Reynolds, E. S., Schlant, R. C., Gonich, H. C., and Dammin, G. J.: Massive necrosis of the liver as a manifestation of hypersensitivity to probenecid. New England J. Med. 256: 592, 1957.
  • 27
    Carr, H. J., and Khauer, Q. F.: Death due to hepatic necrosis in a patient receiving zoxazolamine: Report of a case and review of the literature. New England J. Med. 264: 977, 1961.